Avoro Capital Advisors LLC Sells in Q3 2024

Avoro Capital Advisors LLC

  • $6.65 Billion
  • Q3 2024
Stock Shares change Price Range Shares Held Trade History
BMRN
Biomarin Pharmaceutical Inc

Healthcare
-2.52M
- 55.28%
$69.02 - $93.84 $174M - $236M
2.04M $143M
SRPT
Sarepta Therapeutics, Inc.

Healthcare
-444K
- 14.81%
$124.33 - $156.75 $55.3M - $69.7M
2.56M $319M
MDGL
Madrigal Pharmaceuticals, Inc.

Healthcare
-26.6K
- 1.29%
$212.22 - $292.96 $5.64M - $7.78M
2.03M $431M
IOVA
Iovance Biotherapeutics, Inc.

Healthcare
-7.46M
- 63.76%
$7.28 - $11.9 $54.3M - $88.8M
4.24M $39.8M
FOLD
Amicus Therapeutics, Inc.

Healthcare
-4.23M
- 15.42%
$9.55 - $12.09 $40.3M - $51.1M
23.2M $248M
Spyre Therapeutics Inc
-1.24M
- 67.45%
N/A
599K $0
MNKD
Mannkind Corp

Healthcare
-9.52K
- 0.11%
$5.01 - $6.7 $47.7K - $63.8K
8.75M $55M
BCRX
Biocryst Pharmaceuticals Inc

Healthcare
-705K
- 5.61%
$6.41 - $8.69 $4.52M - $6.13M
11.9M $90.2M
Activity Summary
Buys All Purchases 10 New Holdings 0 Increased Positions 10 Sells All Sells 8 Reductions 8 Sold out 0 Options Calls 0 Puts 1
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email